|
|
|
| home > events calendar |
|
|
 PHARMACEUTICAL INDUSTRY EVENTS CALENDAR |
|
Outsourcing Clinical Trials Nordics 2018
30-31 October 2018
Copenhagen, Denmark
Following on from the success of the 2017 Outsourcing in
Clinical Trials Nordics conference, Arena International is pleased to announce
that the event will return for its 6th year in 2018.
The 2018 event welcomes biopharmaceutical and medical device
companies from across the Nordic region to share knowledge and challenges of
outsourcing and clinical operations. More>> |
|
|
SCOPE Europe: Summit for Clinical Ops Executives
16-17 October 2018
Barcelona, Spain
Building on the
success of its long-running US-based counterpart, Summit for Clinical Trials
Operations Executives Europe (SCOPE Europe) is a two-day event serving clin ops
execs, functional heads, category managers and those responsible for the
planning and management of clinical trials in Europe and the Rest of the World. More>> |
|
|
Clinical Trial Supply East coast 2018
16-17 October 2018
King of Prussia, PA
This unique event brings together leading pharma, device and
biotech professionals from across the East Coast region, to collaboratively
enhance the clinical supply chain. Over the two days, delegates and speakers
will discuss how to select forecasting and planning technology, how to reduce
waste in clinical trials supplies, how to choose your packaging strategy, but
we will also discover all the new technologies that will disrupt your clinical
trials supplies. More>> |
|
|
Drug Discovery 2018
9-10 October 2018
ExCeL Arena, London, UK
ELRIG’s flagship conference, Drug Discovery, has become the
largest meeting of life sciences industry professionals in the UK. Now in its
12th year, Drug Discovery 2018 will take place in London’s Excel Arena. This
2-day event will bring together more than 1200 delegates and over 100
exhibiting companies from around the world who will highlight the latest
ground-breaking research, discuss cutting-edge advances in the application of
laboratory technology to understand disease biology and to identify novel
chemical and biological candidate drugs. More>> |
|
|
PDA Universe of Pre-Filled Syringes and Injection Devices
8 October - 9 November 2018
Loews Royal Pacific, Orlando, FL
At the 2018 PDA Universe of Pre-filled Syringes and Injection Devices,industry and regulatory experts will share experiences, new developments,
regulatory considerations, challenges, and industry trends and best practices.
This is a must-attend event for all industry professionals involved in the
development, manufacturing, testing, or marketing of pre-filled syringes and
injection devices. More>> |
|
|
Clinical Trial Supply Southeast 2018
2-3 October 2018
Cary, North Carolina
Clinical
Trial Supply Southeast will return to Cary, North Carolina for fall 2018. Part
of our global series of events, this show will attract the leading biotech and
pharma companies from the Southeast region, the event will focus on how
companies can adapt their supply chains to fit into the highly regulated world. More>> |
|
|
 |
|
|
 |
Industry Events |
 |
SAPHEX 2018
1-2 November 2018, Gallagher Convention Centre, Midrand, South Africa
The SAPHEX exhibition and conference is now established as the “go-to”
networking and business event for anyone working in the South African
pharmaceutical manufacturing industry.
More info >> |
|
 |
White Papers |
 |
|
Case Study: Cmed’s Mobile Data Management Solution
Cmed Clinical Services
The trial presented to Cmed was a randomized, double blinded, placebo
and active controlled study to evaluate the cardiac safety of multiple
doses of [study drug] in health volunteers.
The pharmaceutical
company, who were into the second year of development of a potential
blockbuster compound for the treatment of chronic myelogenous leukaemia
(CML), were requested by the FDA to design a trial to provide
information on the cardiac safety of different dose levels of the study
drug in healthy adult volunteers. The primary objective of the study was
specifically to find the maximum tolerated dose before QTc levels
became unsafe. All development of the compound was put on hold until the
results of this study were submitted to the FDA and approval granted
for the compound to progress into full development.
More info >> |
|
 |
News and Press Releases |
 |
BioIVT Introduces New Quality Management System to Maintain Highest Quality Biospecimens and Drug Development Research Services
BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it is introducing a new internal cloud-based Quality Management System (QMS), Master Control. This new standardized, ISO compliant QMS will help BioIVT manage documentation, auditing, supplier and customer accounts, and risk across all locations. It will consolidate and replace a variety of computer- and paper-based document control systems located at existing and newly-acquired BioIVT sites in the US, Europe and Asia.
More info >> |
|
|
